Previous 10 |
DOYLESTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $2.3 million for the three months ended March 31, 2019, compared to net sales of $3.4 million for the three months ended March 31, 2018. The Company incu...
DOYLESTOWN, Pennsylvania, April 09, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH , www.ProPhaseLabs.com ) announced a change in the reporting of dividends paid to its stockholders in 2018. The Company previously reported its 2018 distributions as taxable dividends. Foll...
ProPhase Labs (NASDAQ: PRPH ): FY GAAP EPS of -$0.14. More news on: ProPhase Labs, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
DOYLESTOWN, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH , www.ProPhaseLabs.com) today reported its net sales from continuing operations were $13.1 million for the year ended December 31, 2018, as compared to net sales of $9.9 million for the year ended Decem...
DOYLESTOWN, PA, Dec. 26, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of over-the-counter dietary supplements (“ProPhase” or “Company”), an...
ProPhase Labs (NASDAQ: PRPH ): Q2 Non-GAAP EPS of -$0.02. Revenue of $3.2M (+68.4% Y/Y) Press Release More news on: ProPhase Labs, Inc., Earnings news and commentary, Healthcare stocks news, ,
DOYLESTOWN, Pennsylvania, Aug. 20, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH , www.ProPhaseLabs.com) today reported its financial results for the three and six months ended June 30, 2018. Net sales from continuing operations were $3.2 million for the three months ended J...
News, Short Squeeze, Breakout and More Instantly...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Smart...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Sma...
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT. A press release detailing these results...